These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Preventing allograft rejection with CTLA4IG: effect of donor-specific transfusion route or timing. Bolling SF; Lin H; Wei RQ; Turka LA J Heart Lung Transplant; 1996 Sep; 15(9):928-35. PubMed ID: 8889989 [TBL] [Abstract][Full Text] [Related]
9. The new immunology--the end of immunosuppressive drug therapy? Schwartz RS N Engl J Med; 1999 Jun; 340(22):1754-6. PubMed ID: 10352169 [No Abstract] [Full Text] [Related]
10. CTLA4-Ig inhibits rejection of mouse liver allografts from Flt3-ligand-treated donors and is associated with increased lymphocyte apoptosis. Li W; Lu L; Wang Z; Wang L; Thomson A; Fung J; Qian S Transplant Proc; 2001; 33(1-2):246-7. PubMed ID: 11266801 [No Abstract] [Full Text] [Related]
11. [Effect of combined application of external cyclosporine A and CTLA4Ig on the survival of rat auricle allograft]. Cao C; Li SR; Sun ZC; Wang ZX; Luo GX; Wu J Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2002 Jul; 16(4):281-3. PubMed ID: 12181799 [TBL] [Abstract][Full Text] [Related]
12. CD28-B7 T cell costimulatory blockade by CTLA4Ig in sensitized rat recipients: induction of transplantation tolerance in association with depressed cell-mediated and humoral immune responses. Onodera K; Chandraker A; Schaub M; Stadlbauer TH; Korom S; Peach R; Linsley PS; Sayegh MH; Kupiec-Weglinski JW J Immunol; 1997 Aug; 159(4):1711-7. PubMed ID: 9257832 [TBL] [Abstract][Full Text] [Related]
13. CTLA4Ig inhibits airway eosinophilia and hyperresponsiveness by regulating the development of Th1/Th2 subsets in a murine model of asthma. Padrid PA; Mathur M; Li X; Herrmann K; Qin Y; Cattamanchi A; Weinstock J; Elliott D; Sperling AI; Bluestone JA Am J Respir Cell Mol Biol; 1998 Apr; 18(4):453-62. PubMed ID: 9533932 [TBL] [Abstract][Full Text] [Related]
15. Immunosuppression and induction of anergy by CTLA4Ig in vitro: effects on cellular and antibody responses of lymphocytes from rats with experimental autoimmune myasthenia gravis. McIntosh KR; Linsley PS; Drachman DB Cell Immunol; 1995 Nov; 166(1):103-12. PubMed ID: 7585970 [TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated gene transfer of CTLA-4Ig fusion protein in the suppression of experimental autoimmune arthritis. Quattrocchi E; Dallman MJ; Feldmann M Arthritis Rheum; 2000 Aug; 43(8):1688-97. PubMed ID: 10943858 [TBL] [Abstract][Full Text] [Related]
17. Prolongation of rat to mouse skin and heart xenograft survival by combined CTLA4Ig and anti-CD4/CD8 antibody. Tu Y; Rehman A; Flye MW Transplant Proc; 1996 Aug; 28(4):2061-2. PubMed ID: 8769156 [No Abstract] [Full Text] [Related]
18. Prolongation of skin allograft survival in mice treated with CTLA-4 Ig in combination with rapamycin or cyclosporine. Hale DA; Gottschalk R; Wood ML; Maki T; Monaco AP Transplant Proc; 1996 Dec; 28(6):3270-1. PubMed ID: 8962270 [No Abstract] [Full Text] [Related]
19. Long-term graft acceptance in rat heart transplantation by CTLA4Ig gene transfection combined with FTY720 treatment. Ohba M; Li XK; Kita Y; Enosawa S; Funeshima N; Nagai H; Zhang H; Okuyama T; Ogoshi S; Sasaguri S; Amemiya H; Suzuki S World J Surg; 2001 Apr; 25(4):391-7; discussion 397-8. PubMed ID: 11344387 [TBL] [Abstract][Full Text] [Related]
20. Tolerance induction by soluble CTLA4 in a mouse skin transplant model. Tepper MA; Linsley PS; Tritschler D; Esselstyn JM Transplant Proc; 1994 Dec; 26(6):3151-4. PubMed ID: 7998099 [No Abstract] [Full Text] [Related] [Next] [New Search]